Raymond Joseph Tesi - 26 May 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Raymond Joseph Tesi
Issuer symbol
INMB
Transactions as of
26 May 2022
Net transactions value
+$40,383
Form type
4
Filing time
31 May 2022, 06:10:09 UTC
Previous filing
23 Mar 2022
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Purchase $40,383 +6,300 +0.42% $6.41 1,520,698 26 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the average purchase price at a range of between $6.37 and $6.43 per share.